Dean Y. Li - 02 Jan 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
4
Filing time
04 Jan 2024, 18:11:21 UTC
Previous filing
06 Jul 2023
Next filing
11 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1,203 +0.09% $0.000000 1,327,618 02 Jan 2024 Direct F1
holding RXRX Class A Common Stock 1,422,048 02 Jan 2024 By Dean Y. Li Revocable Trust
holding RXRX Class A Common Stock 450,000 02 Jan 2024 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.